BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32396504)

  • 1. Abdominal Visceral Infarction in 3 Patients with COVID-19.
    Besutti G; Bonacini R; Iotti V; Marini G; Riva N; Dolci G; Maiorana M; Spaggiari L; Monelli F; Ligabue G; Guaraldi G; Rossi PG; Pattacini P; Massari M
    Emerg Infect Dis; 2020 Aug; 26(8):1926-1928. PubMed ID: 32396504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.
    D'Andrea S; Berardicurti O; Berardicurti A; Felzani G; Francavilla F; Francavilla S; Giacomelli R; Barbonetti A
    Spinal Cord Ser Cases; 2020 Aug; 6(1):69. PubMed ID: 32753638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
    Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting.
    Davoodi L; Jafarpour H; Taghavi M; Razavi A
    J Investig Med High Impact Case Rep; 2020; 8():2324709620931239. PubMed ID: 32493073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
    Valente-Acosta B; Moreno-Sanchez F; Fueyo-Rodriguez O; Palomar-Lever A
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32587121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
    Miao H; Li H; Yao Y; Wu M; Lu C; Wang J; Tian M; Li Y; Luo P; Gu J; Yuan B; Wang S; Zhao X; Gan W; Zhao D
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2211-2223. PubMed ID: 32761481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.
    Zeng JH; Liu YX; Yuan J; Wang FX; Wu WB; Li JX; Wang LF; Gao H; Wang Y; Dong CF; Li YJ; Xie XJ; Feng C; Liu L
    Infection; 2020 Oct; 48(5):773-777. PubMed ID: 32277408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians.
    Attanasi M; Pasini S; Caronni A; Pellegrino GM; Faverio P; Di Pillo S; Cimino MM; Cipolla G; Chiarelli F; Centanni S; Sferrazza Papa GF;
    Respiration; 2020; 99(8):667-677. PubMed ID: 32756065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection.
    Di Perri G
    Infez Med; 2020 Jun; 28(suppl 1):52-56. PubMed ID: 32532939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2.
    Zhang H; Xie C; Huang Y
    J Thorac Oncol; 2020 May; 15(5):e63-e64. PubMed ID: 32147577
    [No Abstract]   [Full Text] [Related]  

  • 14. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA; Rezai S; Cleland E; Henderson CE
    Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.
    Stalder G; Alberio L
    Blood; 2020 Aug; 136(7):915. PubMed ID: 32790855
    [No Abstract]   [Full Text] [Related]  

  • 17. Venous thromboembolism and COVID-19.
    Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O
    Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
    Sekhavati E; Jafari F; SeyedAlinaghi S; Jamalimoghadamsiahkali S; Sadr S; Tabarestani M; Pirhayati M; Zendehdel A; Manafi N; Hajiabdolbaghi M; Ahmadinejad Z; Kouchak HE; Jafari S; Khalili H; Salehi M; Seifi A; Golestan FS; Ghiasvand F
    Int J Antimicrob Agents; 2020 Oct; 56(4):106143. PubMed ID: 32853672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient.
    Gómez-Enjuto S; Hernando-Requejo V; Lapeña-Motilva J; Ogando-Durán G; Fouz-Ruiz D; Domingo-García J; Rodríguez-García E; Cemillán-Fernández CA
    Seizure; 2020 Aug; 80():157-158. PubMed ID: 32574838
    [No Abstract]   [Full Text] [Related]  

  • 20. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
    Tadolini M; Codecasa LR; García-García JM; Blanc FX; Borisov S; Alffenaar JW; Andréjak C; Bachez P; Bart PA; Belilovski E; Cardoso-Landivar J; Centis R; D'Ambrosio L; Luiza De Souza-Galvão M; Dominguez-Castellano A; Dourmane S; Fréchet Jachym M; Froissart A; Giacomet V; Goletti D; Grard S; Gualano G; Izadifar A; Le Du D; Marín Royo M; Mazza-Stalder J; Motta I; Ong CWM; Palmieri F; Rivière F; Rodrigo T; Silva DR; Sánchez-Montalvá A; Saporiti M; Scarpellini P; Schlemmer F; Spanevello A; Sumarokova E; Tabernero E; Tambyah PA; Tiberi S; Torre A; Visca D; Zabaleta Murguiondo M; Sotgiu G; Migliori GB
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32457198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.